BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  New Data to be Presented on Key Basilea Pharmaceutica Compounds at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

  September 13, 2007

   · 

  1 min read
• Drug Development

  Vernalis PLC Says “Striking” Results for Obesity Drug

  September 13, 2007

   · 

  1 min read
• Lone Star Bio

  Advanced Materials Inc.'s Three-Tiered Growth Plan Takes Shape

  September 13, 2007

   · 

  1 min read
• Lone Star Bio

  Opexa Therapeutics to Present at the First Annual Maxim Group Growth Conference

  September 13, 2007

   · 

  1 min read
• Business

  Cambridge Laboratories Limited Appoints Peter Butterfield as UK Commercial Manager

  September 13, 2007

   · 

  1 min read
• Policy

  FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals, Inc.

  September 13, 2007

   · 

  4 min read
• Drug Development

  Anesiva, Inc. Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery

  September 13, 2007

   · 

  5 min read
• Drug Development

  Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)

  September 13, 2007

   · 

  7 min read
• Pharm Country

  Cephalon, Inc. Warns Doctors Over Pain Drug Deaths Says FDA

  September 13, 2007

   · 

  6 min read
• Lone Star Bio

  University of Texas-Houston Start-Up Will Develop Nanostructured CT Contrast Agents

  September 13, 2007

   · 

  1 min read